Meskacel™ L-HPC LP22

Meskacel™ L-HPC LP22
Product Description

Meskacel™ L-HPC LP22 power (Low-substituted hydroxypropyl cellulose LP22) is a high-performance pharmaceutical excipient. Its unique physicochemical properties make it a core disintegrant and filler for tablets, capsules, and sustained-release preparations. It is suitable for wet granulation, dry granulation, and direct tablet pressing processes. It can accelerate drug release and enhance drug bioavailability.

Meska Joinway Pharmaceutical Co.,Ltd.

  • Country/Region:
    China
  • Founded:
    2003
  • On CPHI since:
    2023
  • Certificates:
    5
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Excipients Manufacturer
Specifications
  • CAS Registry Number
    9004-64-2
  • Details
    In the direct tablet pressing process, L-HPC LP22, as an excellent dry binder and disintegrant, is particularly suitable for the tablet preparation of heat-sensitive drugs and drugs sensitive to moisture; During the wet granulation process, L-HPC LP22 can be mixed with other excipients for granulation.It plays a disintegrating role in the tablets, enabling them to disintegrate rapidly in the body and release the active ingredients of the drug; They can be used to prepare oral rapid-disintegrating tablets. Their rapid disintegration property enables the tablets to disintegrate quickly in the mouth without the need for water administration, making them convenient for patients to use. 


  • Model
    LP22
  • Supplied from
    China
  • Measured In
    kilogram

Meska Joinway Pharmaceutical Co.,Ltd.

  • Country/Region:
    China
  • Founded:
    2003
  • On CPHI since:
    2023
  • Certificates:
    5
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
API Producer
Biopharmaceutical
Excipients Manufacturer

More Products from Meska Joinway Pharmaceutical Co.,Ltd. (15)

  • Meskacel™HPMC E50

    Product Meskacel™HPMC E50

    Meskacel™HPMC E50 powder (hydroxypropyl methyl cellulose) is a low-viscosity biocompatible medical excipient that can form a dense gel barrier to achieve long-acting drug sustained release (such as postoperative analgesic gel release time ≥72 hours). It is characterised by high purity, high perfo...
  • Meskacel™ HPMC E4M

    Product Meskacel™ HPMC E4M

    Medical-grade Meskacel™ HPMC E4M powder (hydroxypropyl methylcellulose) is a nonionic cellulose ether. When HPMC E4M is used as a pharmaceutical excipient, it regulates drug release through a synergistic mechanism of swelling-diffusion (Fickian diffusion) and dissolution-diffusion (non-Fickian diffusi...
  • Meskacel™ HPMC K100

    Product Meskacel™ HPMC K100

    Medical-grade Meskacel™ HPMC K100 powder (hydroxypropyl methylcellulose) features low viscosity, high drug loading compatibility and excellent biocompatibility. Viscosity range (100±20 mPa·s, 2% aqueous solution at 20℃), suitable for drug-controlled release, skin barrier repair and mucosal d...
  • Meskacel™ HPMC K4M

    Product Meskacel™ HPMC K4M

    Meskacel™ HPMC K4M powder (Hydroxypropyl methylcellulose) is a nonionic cellulose ether and a high-viscosity modifier specially designed for the pharmaceutical industry. Meska Joinway, a Chinese HPMC supplier, sells HPMC K4M powder of excellent quality.
  • Meskacel™ HPMC K15M

    Product Meskacel™ HPMC K15M

    Pharmaceutical-grade HPMC K15M powder is a nonionic cellulose ether, chemically modified from natural cellulose, and has excellent water solubility and adhesion. Its nominal viscosity is 15,000 mPa · s (2% aqueous solution, 20℃).
  • Meskacel™ L-HPC LP11

    Product Meskacel™ L-HPC LP11

    Meskacel™ L-HPC LP11 powder (low-substituted hydroxypropyl cellulose) achieves efficient disintegration through capillary permeation and hydrogen bond breaking mechanism based on its low degree of substitution (≤11%) and porous microcrystalline structure. Its high porosity (≥60%) enables it ...
  • Pharma Grade Hydroxypropyl Cellulose (HPC)

    Product Pharma Grade Hydroxypropyl Cellulose (HPC)

    Meska Joinway's pharmaceutical-grade hydroxypropyl cellulose (HPC) is a high-purity, non-ionic, water-soluble cellulose ether derived from chemically modified natural cellulose. It exhibits excellent solubility in water and various polar organic solvents and offers multiple functional proper...
  • Meskacel™ HPMC E5

    Product Meskacel™ HPMC E5

    Meskacel™ HPMC E5 powder (hydroxypropyl methylcellulose) is a nonionic cellulose ether, specially designed for rapid release preparations. Its core advantages include:
    Low viscosity (5-10 mPa·s for 2% solution): Good fluidity, suitable for direct tablet pressing and wet granulation.
    Rapid solubility:...
  • Meskacel™ HPMC K100M

    Product Meskacel™ HPMC K100M

    The viscosity of Meskacel™ HPMC K100M powder 5% aqueous solution reaches 100,000±10% cps (at 20℃, Brookfield method). After absorbing water, it rapidly expands to form a dense hydrated gel layer, significantly delaying drug release. It is suitable for medical-grade 24-hour long-acting s...
  • Meskacel™ L-HPC LP21

    Product Meskacel™ L-HPC LP21

    As a nonionic polymer, L-HPC LP21 power has stable chemical properties, is not prone to chemical reactions with drugs, has little impact on the therapeutic effect of drugs, contains no peroxides, and cooperates well with oxygen-sensitive active drug components, ensuring the quality and stability ...
  • Pharma Grade Methyl Cellulose (MC)

    Product Pharma Grade Methyl Cellulose (MC)

    Methyl cellulose (MC) is a safe, stable pharmaceutical excipient. Meska Joinway produces high-quality MC that meets GMP standards for reliable, consistent products. Its products have the following functions:
    · Increases the viscosity of the liquid, making the formulation more stable;
    · Help...
  • Meskacel™ HPMC E3

    Product Meskacel™ HPMC E3

    Meskacel™ HPMC E3 powder, pharmaceutical-grade hydroxypropyl methyl cellulose, has become an ideal choice in the pharmaceutical industry due to its outstanding performance and strict quality standards. The hydrophilic groups in its molecular structure endow it with properties such as thickening and adhesio...

Meska Joinway Pharmaceutical Co.,Ltd. resources (3)

  • Brochure MESKACEL PHARMACEUTICAL EXCIPIENTS-PRODUCT BROCHURE

    Meska Joinwray Pharmaceutical Co., Ltd. has been a trusted manufacturer ofpharmaceutical excipients since its establishment in 2003,operating in fullcompliance with Good Manufacturing Practice (GMP') standards.wespecialize in praviding a comprehensive portfolio of cellulose ethers andhigh-performance excipients designed to optimize formulationdevelopment, imprave solubility, and enhance the delivery of activepharmaceutical ingredients.Since 2003,Meska Joinway has built a strong global presence, servingcustomers across multiple countries and fostering long-term,reliablepartnerships in the pharmaceutical industry.

  • Brochure MESKA JOINWAY PHARMACEUTICAL CO., LTD-PRODUCT BROCHURE

    Meska Joinway Pharmaceutical Co., Ltd., established in 2003, specializes in the production and operation of a variety of new pharmaceutical-grade and industrial-grade cellulose ethers. Its pharmaceutical-grade cellulose related products are technologically leading in China. They are widely used in plant hollow capsules, film coating powders and related film-forming agents, sustained-release and controlled-release dosage form matrix materials, solid dosage form binders, stabilizers for ointments and emulsifiable concentrates, and thickening agents for lotions and gels.

     

  • Video Meska Joinway Pharmaceutical Co., Ltd - Corporate Video

    Meska Joinway is a high-tech enterprise with over 20 years of experience in the production and sales of new pharmaceutical excipients and various industrial cellulose ethers. It is located in the provincial chemical industrial park of Linghu Town, Nanxun District, Huzhou City, China. The total investment in the construction of the factory area is $ 187 million, with a land area of approximately 94,000 square meters and an annual production capacity of 38,000 tons of cellulose ethers. The company has established a talent-driven pattern centered on innovation and R&D, with the proportion of professional and technical personnel dedicated to new product R&D exceeding 20%. Currently, research and development bases for new types of pharmaceutical excipients, pharmaceutical intermediates, preparations, and various industrial cellulose ethers have been established.